SEVENTY
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SEVENTY, covering 2025-12-16 to 2025-12-16. Get the full timeline:
Most recent: Clinical Trial Update: Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY) [Phase 1]